Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00141934 · ClinicalTrials.gov registry record · Phase 2

A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.

A Phase 2 study of Rheumatoid Arthritis, sponsored by Sosei.

Completed
Registry status
Phase 2
Development phase
232
Enrollment target
10
Study locations

NCT00141934 is a Phase 2 study of Rheumatoid Arthritis that has completed, run by Sosei. The registered enrollment target is 232 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (95% lower). The trial reports 10 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00141934, a Phase 2 study of Rheumatoid Arthritis, has completed, sponsored by Sosei.

COMPLETED
Registry status
Phase 2
Development phase
232 participants
Enrollment target
10
Study locations

Study Summary

AD 452 is a new drug which is being developed for use in adult patients with RA. It is believed that AD 452 may modify the underlying disease of RA as well as improving RA symptoms, and in order to establish its efficacy and safety, AD 452 is being tested in a 3 month study. Patients enrolled in this study will already be taking methotrexate for their RA and they will remain on methotrexate throughout the study. An earlier clinical study in 98 subjects with RA on stable background therapy investigated the pharmacokinetics, safety and tolerability of AD 452 taken for one month. The drug was well tolerated and no significant drug related adverse events were reported.

Conditions Studied

Rheumatoid Arthritis

Interventions

  • DRUG AD 452

Study Locations (10)

Florida

  • Clinical Research of West Florida, Inc - Clearwater
  • Center for Rheumatology, Immunology and Arthritis - Fort Lauderdale
  • Ocala Rheumatology Research Center - Ocala
  • Sarasota Arthritis Research Center - Sarasota
  • Advent Clinical Research Centers, Inc. - St. Petersburg

New Jersey

  • Anderson and Collins Clinical Research, Inc. - Edison
  • Station Avenue - Haddon Heights
  • Atlantic Coast Research LLC - Toms River

Maryland

  • Dept of Rheumatology, Columbia Medical Practice - Columbia

Pennsylvania

  • Rheumatic Disease Associates - Willow Grove

Trial Details

FieldValue
Enrollment Target 232 participants
Start Date 2005-08
Phase Phase 2

Sponsor

Sosei

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00141934

The ClinicalTrials.gov registry entry for NCT00141934 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (95% lower). The listed sponsor is Sosei, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which AD 452 is the first listed.

NCT00141934 reports 10 study locations spanning 4 distinct geographic areas - top geographies include Florida, New Jersey, Maryland.

Frequently Asked Questions

What is clinical trial NCT00141934 about?

NCT00141934 is a clinical study titled "A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.". AD 452 is a new drug which is being developed for use in adult patients with RA. It is believed that AD 452 may modify the underlying disease of RA as well as improving RA symptoms, and in order to establish its efficacy and safety, AD 452 is being tested in a 3 month study. Patients enrolled in thi...

What is the current status of trial NCT00141934?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 232 participants. The study started on 2005-08.

What conditions does trial NCT00141934 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT00141934?

The interventions under investigation include: AD 452 (DRUG).

Who is sponsoring clinical trial NCT00141934?

This trial is sponsored by Sosei, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00141934 being conducted?

This trial has 10 study locations across Florida, Maryland, New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.